Skip to content
healthcare.dev

Rivastigmine

NDC 0781-7313, rivastigmine, patch, extended release, from Sandoz Inc.

Product NDC
0781-7313
Status
Listed
Labeler
Sandoz Inc
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022083
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0781-7313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE13.3 mg/24h

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
0781-7313-310078173133130 PATCH in 1 CARTON (0781-7313-31) / 24 h in 1 PATCH (0781-7313-58)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/92a58ebb-748d-49f4-bf11-ecbcf5424152
  • NADAC price for package 00781731331

    GET /v1/drugs/nadac/00781731331

Use it

Look up 0781-7313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0781-7313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0781-7313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.